Skip to main content

Global Clinical Nutrition Market: 7% Growth and the Role of Nutrition in Managing Age-Related Diseases by 2030

 The global clinical nutrition market is set to witness a growth rate of 7% in the next 5 years. Increasing aging population and chronic diseases; rising prevalence of malnutrition; growing rates of preterm births worldwide; rising awareness about the role of clinical nutrition in disease prevention and management; and advancements in clinical nutrition products are some of the key factors driving the clinical nutrition market. 

Clinical nutrition is a specialized field of healthcare focused on the prevention, diagnosis, and management of nutritional and metabolic disorders. It involves the use of tailored nutritional interventions to address the specific dietary needs of individuals with medical conditions, such as chronic diseases, malnutrition, or recovery from surgery or illness. Clinical nutrition includes enteral nutrition (administered via the gastrointestinal tract) and parenteral nutrition (delivered intravenously) to ensure patients receive essential nutrients for optimal health outcomes. It plays a critical role in supporting recovery, improving quality of life, and enhancing clinical outcomes in both hospital and homecare settings. 

📥 Get the sample report to explore market trends, opportunities, and competitive insights: https://meditechinsights.com/global-clinical-nutrition-market/request-sample/ 

Increasing aging population and chronic diseases to propel market demand 

The increasing aging population and prevalence of chronic diseases are significant drivers of the clinical nutrition market. Older adults often experience reduced metabolic efficiency, nutrient absorption issues, and higher susceptibility to chronic conditions like diabetes, cardiovascular diseases, and cancer. These factors necessitate specialized nutritional support to manage health, enhance recovery, and improve quality of life. Clinical nutrition addresses malnutrition and supports patients undergoing treatment or rehabilitation. The growing number of elderly individuals globally, coupled with the rising incidence of chronic diseases, boosts the demand for tailored nutritional solutions, fueling market growth in hospitals, long-term care facilities, and homecare settings. 

Rising awareness about the role of clinical nutrition in disease prevention and management is driving the market growth 

Rising awareness about the critical role of clinical nutrition in disease prevention and management is a significant driver of the clinical nutrition market. Increasing education among healthcare providers and patients highlights how proper nutrition supports immunity, enhances recovery, and reduces the risk of disease progression. Preventive healthcare trends emphasize the importance of nutritional interventions in mitigating chronic conditions like diabetes and cardiovascular diseases. Additionally, government campaigns and advocacy by health organizations further boost public understanding of clinical nutrition's benefits. This growing awareness encourages adoption in both clinical settings and at-home care, driving market growth globally. 

Competitive Landscape Analysis 

The global clinical nutrition market is marked by the presence of established and emerging market players such as Abbott, Pfizer Inc., Bayer AG, Nestlé Health Science, Baxter, Otsuka Pharmaceutical Co., Ltd., Danone, Fresenius SE & Co. KGaA, Mead Johnson & Company, LLC., and Perrigo Company plcnone; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion. 

 

Get PDF Report for Competitive Analysis:

https://meditechinsights.com/global-clinical-nutrition-market/request-sample/ 

Market Segmentation 

This report by Medi-Tech Insights provides the size of the global clinical nutrition market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product, route of administration, indication, sales channel, end user, and region

  • Market Size & Forecast (2023-2030), By Product, USD Million
    • Infant Nutrition
      • Milk-based Formula
      • Soy-based Formula
      • Organic Formula
    • Enteral Nutrition
      • Standard Formula
      • Disease-specific Formula
    • Parenteral Nutrition
      • Amino Acids
      • Carbohydrates
      • Lipid Emulsions
      • Vitamins & Minerals
      • Trace Elements
  • Market Size & Forecast (2023-2030), By Route of Administration, USD Million
    • Oral
    • Enteral
    • Parenteral
  • Market Size & Forecast (2023-2030), By Indication, USD Million
    • Chronic Diseases
      • Cancer
      • Diabetes
      • Cardiovascular Diseases
      • Other Chronic Diseases
    • Malnutrition
    • Neurological Disorders
    • Gastrointestinal Disorders
    • Orphan Diseases
    • Pain Management
    • Dysphagia
    • Others
  • Market Size & Forecast (2023-2030), By Sales Channel, USD Million
    • Online Sales Channels
    • Retail Sales Channels
    • Institutional Sales Channels
    • Others
  • Market Size & Forecast (2023-2030), By End User, USD Million
    • Hospitals & Clinics
    • Long-term Care Facilities
    • Homecare Settings
    • Others
  • Market Size & Forecast (2023-2030), By Region, USD Million
    • North America
      • US
      • Canada
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Rest of Asia Pacific
    • Latin America
    • Middle East & Africa

 

About Medi-Tech Insights 

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers. 

Contact: 

Ruta Halde 
Associate, Medi-Tech Insights 
+32 498 86 80 79  
info@meditechinsights.com  

Comments

Post a Comment

Popular posts from this blog

Global Biotechnology Market to grow at 13–15% CAGR as CRISPR use expands globally by 2029

  The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years.  Advancements in genetic engineering and genomics; growing demand for biopharmaceuticals; rising incidence of chronic diseases; growth in environmental and agricultural biotechnology; increased investment in R&D; growing demand for synthetic biology; and presence of favorable government initiatives are some of the key factors driving the biotechnology market. Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop r...
Post a Comment
Read more

Global Multi Cancer Early Detection Market expanding 15–20% CAGR through personalized care 2030

  The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period.  This growth is primarily due to the rising awareness and increasing demand for early-stage screening tools, especially as cancer rates continue to rise globally, and technological advancements in screening methods. However, high costs and strict regulations can still hinder the market growth.  Multi Cancer Early Detection (MCED) refers to tests designed to detect multiple cancers, often from a single blood sample, unlike traditional methods, which can include multiple diagnostic tests or biopsies. These tests look for signs like DNA methylation patterns or small traces of tumor DNA floating in the bloodstream. The primary goal is early cancer detection, ideally before any symptoms appear, so the overall treatment is more effective and less expensive. Download a free sample report now 👉 https://meditechinsights.com/multi-cancer-early-detection-marke...
Post a Comment
Read more

Global Structural Heart Devices Market growth 9% CAGR with favorable reimbursement scenarios 2030

  The global structural heart devices market is set to witness a CAGR of ~9% in the next 5 years.  The rising geriatric population & corresponding rise in the prevalence of heart disease, technological advancements in structural heart devices, regulatory approval for expanded indications for several transcatheter heart valves, and increasing awareness and favorable reimbursements for these procedures in key markets are some of the pivotal factors driving the growth of the structural heart devices market. However, high device costs, complex procedures, and stringent regulatory hurdles continue to restrain market uptake.  Structural heart disease occurs when something is wrong with one’s heart valves, walls, chambers or muscles. It exists from birth or develops as one age. It includes conditions such as congenital heart disease, cardiomyopathy, and heart valve disease. Heart valve devices, occluders & delivery systems, annuloplasty rings, heart access systems, cl...
Post a Comment
Read more